��������

Mr. Moriarty is an entrepreneur with more than four decades of experience in the pharmaceutical industry. He currently is the Chief Executive Officer and owner of The Synapse Group, Inc., a specialty consulting practice with operations in the United States and Canada. Synapse has helped pioneer programs and processes that address the unique information requirements of medical specialists working in technically-sophisticated fields including organ transplantation, cancer, infectious disease, rheumatology, immunology, cardiovascular disease, and vaccines.

Mr. Moriarty spent the first 13 years of his career working for two large multi-national pharmaceutical manufacturers, where he progressed through positions of increasing responsibility in marketing management, new business development, product acquisition and licensing clinical operations, and regulatory affairs. He is a member of the board of directors of BlueRush Media Group Corp. located in Toronto, Canada, and Lisoma Canada, a subsidiary of Lisoma International Ltd, a pharmaceutical manufacturer located in the United Kingdom.

Mr. Moriarty received his bachelor of science degree from St. Francis Xavier University.